Back
HFA Premium Access

Eligibility for simultaneous initiation of the four pharmacological pillars of heart failure with reduced ejection fraction at discharge

Session: Acute heart failure - treatment 2
Topic: Pharmacotherapy
Speaker: Doctor D. Rodolico (Pisa, IT)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Daniele Rodolico

Pisa (Italy)
0 follower

6 more presentations in this session

Phenotype-specific prognosis of hypochloremia in acute heart failure

Speaker: Doctor F. Croset (Madrid, ES)

Access
Abstract
Slides
Like
Thumbnail

Feasibility, safety and efficacy of spot urinary sodium guided titration of intravenous diuretic therapy in acute heart failure: a randomised controlled trial

Speaker: Doctor M. Khorramshahi Bayat (Brisbane, AU)

Access
Abstract
Slides
Like
Thumbnail

Improved mortality and hemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure

Speaker: Doctor E. Rodenas Alesina (Barcelona, ES)

Access
Abstract
Slides
Like
Thumbnail

Ivabradine effects in hospitalized acute heart failure patients

Speaker: Doctor A. Almaghraby (Ras Al Khaimah, AE)

Access
Abstract
Slides
Like
Thumbnail

Influence of adherence and optimal pharmacological treatment on survival rates of hospitalized patients with decompensated heart failure

Speaker: Doctor B. Wajsbrot (Rio de Janeiro, BR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Acute heart failure - treatment 2

Speakers: Doctor D. Rodolico, Doctor F. Croset, Doctor M. Khorramshahi Bayat, Doctor E. Rodenas Alesina, Doctor A. Almaghraby...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources